After a broadly optimistic and reform-driven 2024, this year saw momentum beging to shift once again for the global cannabis
As Europe’s medical cannabis market shifts from a focus on growth to pharmaceutical discipline, PHCANN International has emerged as a
In the latest instalment of our series spotlighting expert contributors to Prohibition Partners’ newly launched Insights Hub, we spoke with
Telemedicine and access to medical cannabis via online platforms have become a central issue in Germany’s cannabis sector, drawing scrutiny
We won’t spam you
